Accent Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21K | Hold |
40
| – | – | 0.01% | 164 |
|
|
2025
Q1 | $25.4K | Sell |
40
-35
| -47% | -$22.2K | 0.01% | 143 |
|
|
2024
Q4 | $53.4K | Hold |
75
| – | – | 0.03% | 77 |
|
|
2024
Q3 | $78.8K | Hold |
75
| – | – | 0.05% | 81 |
|
|
2024
Q2 | $78.8K | Hold |
75
| – | – | 0.05% | 80 |
|
|
2024
Q1 | $72.2K | Hold |
75
| – | – | 0.06% | 65 |
|
|
2023
Q4 | $65.9K | Buy |
+75
| New | +$65.9K | 0.05% | 85 |
|